SEC FORM 4
$35,530.88
OCULAR THERAPEUTIX, INC (OCUL)
Sale of 3,296 shares at $10.78 per share.
Reporting Person Heier Jeffrey S. · Officer Title Chief Scientific Officer · Transaction Code S
Traded Aug 24, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001104659-26-101670 · filed 2026-08-26 · View filing →